Abstract
Validation of quantitative structure-activity relationship (QSAR) models plays a key role for the selection of robust and predictive models that may be employed for further activity prediction of new molecules. Traditionally, QSAR models are validated based on classical metrics for internal (Q2) and external validation (R2 pred). Recently, it has been shown that for data sets with wide range of the response variable, these traditional metrics tend to achieve high values without truly reflecting absolute differences between the observed and predicted response values, as in both cases the reference for comparison of the predicted residuals is the deviations of the observed values from the training set mean. Roy et al. have recently developed a new parameter, modified r2 (rm 2), which considers the actual difference between the observed and predicted response data without consideration of training set mean thereby serving as a more stringent measure for assessment of model predictivity compared to the traditional validation parameters (Q2 and R2 pred). The rm 2 parameter has three different variants: (i) rm 2 (LOO) for internal validation, (ii) rm 2 (test) for external validation and (iii) rm 2 (overall) for analyzing the overall performance of the developed model considering predictions for both internal and external validation sets. Thus, the rm 2 metrics strictly judge the ability of a QSAR model to predict the activity/toxicity of untested molecules. The present review provides a survey of the development of different rm 2 metrics followed by their applications in modeling studies for selection of the best QSAR models in different reports made by several workers.
Keywords: QSAR, rm2 metrics, Internal validation, external validation, ecotoxicological, LOO-Q2, LOO, R2 pred, Saccharomyces cerevisiae, physicochemical descriptors, Tetranychus urticae
Mini-Reviews in Medicinal Chemistry
Title:On the Use of the Metric rm 2 as an Effective Tool for Validation of QSAR Models in Computational Drug Design and Predictive Toxicology
Volume: 12 Issue: 6
Author(s): K. Roy and I. Mitra
Affiliation:
Keywords: QSAR, rm2 metrics, Internal validation, external validation, ecotoxicological, LOO-Q2, LOO, R2 pred, Saccharomyces cerevisiae, physicochemical descriptors, Tetranychus urticae
Abstract: Validation of quantitative structure-activity relationship (QSAR) models plays a key role for the selection of robust and predictive models that may be employed for further activity prediction of new molecules. Traditionally, QSAR models are validated based on classical metrics for internal (Q2) and external validation (R2 pred). Recently, it has been shown that for data sets with wide range of the response variable, these traditional metrics tend to achieve high values without truly reflecting absolute differences between the observed and predicted response values, as in both cases the reference for comparison of the predicted residuals is the deviations of the observed values from the training set mean. Roy et al. have recently developed a new parameter, modified r2 (rm 2), which considers the actual difference between the observed and predicted response data without consideration of training set mean thereby serving as a more stringent measure for assessment of model predictivity compared to the traditional validation parameters (Q2 and R2 pred). The rm 2 parameter has three different variants: (i) rm 2 (LOO) for internal validation, (ii) rm 2 (test) for external validation and (iii) rm 2 (overall) for analyzing the overall performance of the developed model considering predictions for both internal and external validation sets. Thus, the rm 2 metrics strictly judge the ability of a QSAR model to predict the activity/toxicity of untested molecules. The present review provides a survey of the development of different rm 2 metrics followed by their applications in modeling studies for selection of the best QSAR models in different reports made by several workers.
Export Options
About this article
Cite this article as:
Roy K. and Mitra I., On the Use of the Metric rm 2 as an Effective Tool for Validation of QSAR Models in Computational Drug Design and Predictive Toxicology, Mini-Reviews in Medicinal Chemistry 2012; 12 (6) . https://dx.doi.org/10.2174/138955712800493861
DOI https://dx.doi.org/10.2174/138955712800493861 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation
Current Cancer Drug Targets Quasi-Life Self-Organizing Systems: Based on Ensembles of Succinylated Derivatives of Interferon-Gamma
Current Medicinal Chemistry COVID-19 and Kidney Disease: A Clinical Perspective
Current Vascular Pharmacology The Perfect Storm: A Rheumatologist's Point of View on COVID-19 Infection
Current Rheumatology Reviews Actual Knowledge of Systemic Inflammation Reaction During Cardiopulmonary Bypass
Recent Patents on Cardiovascular Drug Discovery New Lead Generation Strategies for Protein Kinase Inhibitors - Fragment Based Screening Approaches
Mini-Reviews in Medicinal Chemistry The Evolving Landscape in the Development of Isocitrate Dehydrogenase Mutant Inhibitors
Mini-Reviews in Medicinal Chemistry Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitors for New Anti-Diabetic Agent
Current Topics in Medicinal Chemistry 2,4,6-Trichlorophenylhydrazine Schiff Bases as DPPH Radical and Super Oxide Anion Scavengers
Medicinal Chemistry ACE2 as a Potential Target for Management of Novel Coronavirus (nCoV- 2019)
Current Drug Discovery Technologies Inhibition of 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase (Dxr): A Review of the Synthesis and Biological Evaluation of Recent Inhibitors
Current Topics in Medicinal Chemistry Anti-MRSA Cephems: An Update
Current Medicinal Chemistry - Anti-Infective Agents Design, Synthesis, Antioxidant and Anticancer Activity of New Coumarin Derivatives Linked with Thiazole, Isoxazole or Pyrazole Moiety
Letters in Drug Design & Discovery Cosalane and its Analogues: A Unique Class of Anti-HIV Agents
Mini-Reviews in Medicinal Chemistry Serotonin Reuptake Inhibitors: The Corner Stone in Treatment of Depression for Half a Century – A Medicinal Chemistry Survey
Current Topics in Medicinal Chemistry COVID-19 Tests and International Travel: How Long Will You Test Positive for SAR-CoV-2?
Current Respiratory Medicine Reviews Role of Molecular Analysis After Autopsy Negative Sudden Death in the Young
Current Pediatric Reviews <i>In Silico</i> Insight into the Inhibitory Effects of Active Antidiabetic Compounds from Medicinal Plants Against SARS-CoV-2 Replication and Posttranslational Modification
Coronaviruses Neurocysticercosis: The Enigmatic Disease
Central Nervous System Agents in Medicinal Chemistry Combat Pneumococcal Infections: Adhesins as Candidates for Protein- Based Vaccine Development
Current Drug Targets